Galmed Pharmaceuticals Ltd. buy Royal Bank of Canada
Start price
07.08.24
/
50%
€0.26
Target price
07.08.25
€71.40
Performance (%)
0.00%
Price
07.08.24
€0.26
Summary
This prediction is currently active. Royal_Bank_of_Canada's BUY prediction for Galmed Pharmaceuticals Ltd. is currently unchanged. This prediction currently runs until 07.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Galmed Pharmaceuticals Ltd. | 0.00% |
iShares Core DAX® | -1.941% |
iShares Nasdaq 100 | -3.642% |
iShares Nikkei 225® | -2.728% |
iShares S&P 500 | -3.440% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Royal Bank of Canada from $76.00 to $78.00. They now have an "outperform" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.41
11.01.24
11.01.24
€63.93
11.01.25
11.01.25
-37.20%
07.08.24
07.08.24